logo
Plus   Neg
Share
Email

Roche Unveils New Quantitative Antibody Test To Measure SARS-CoV-2 Antibodies

Swiss drug maker Roche Group (RHHBY) announced Friday the launch of its Elecsys Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark.

The company has filed for Emergency Use Authorisation or EUA from the U.S. Food and Drug Administration. The new test is expected to support the evaluation of vaccines.

The new Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 or SARS-CoV-2. The test targets antibodies against the spike protein. This is the focus of vaccines in development and convalescent plasma therapy.

The new test is the twelfth in the Roche SARS-CoV-2 testing portfolio.

Roche noted that the new Elecsys Anti-SARS-COV-2 S antibody test, together with the Elecsys Anti-SARS-CoV-2 test launched in May, can help to more effectively determine the percentage of a population who already have antibodies against SARS-COV-2.

Thomas Schinecker, CEO Roche Diagnostics, said, "As the possibility of an effective SARS-CoV-2 vaccine becomes a reality, quantitative measurement of antibodies will be crucial in the evaluation of any potential vaccine. The new quantitative Elecsys antibody test can play a pivotal role in vaccine clinical trials as well as helping clinicians assess patients immune response."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT